These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25299404)

  • 1. mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.
    Tellam JT; Zhong J; Lekieffre L; Bhat P; Martinez M; Croft NP; Kaplan W; Tellam RL; Khanna R
    PLoS Pathog; 2014 Oct; 10(10):e1004423. PubMed ID: 25299404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
    Tellam JT; Lekieffre L; Zhong J; Lynn DJ; Khanna R
    PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.
    Murat P; Zhong J; Lekieffre L; Cowieson NP; Clancy JL; Preiss T; Balasubramanian S; Khanna R; Tellam J
    Nat Chem Biol; 2014 May; 10(5):358-64. PubMed ID: 24633353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation efficiency of EBNA1 encoded by lymphocryptoviruses influences endogenous presentation of CD8+ T cell epitopes.
    Tellam J; Rist M; Connolly G; Webb N; Fazou C; Wang F; Khanna R
    Eur J Immunol; 2007 Feb; 37(2):328-37. PubMed ID: 17236233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.
    Tellam J; Smith C; Rist M; Webb N; Cooper L; Vuocolo T; Connolly G; Tscharke DC; Devoy MP; Khanna R
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9319-24. PubMed ID: 18591662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
    Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
    PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
    Reznichenko O; Quillévéré A; Martins RP; Loaëc N; Kang H; Lista MJ; Beauvineau C; González-García J; Guillot R; Voisset C; Daskalogianni C; Fåhraeus R; Teulade-Fichou MP; Blondel M; Granzhan A
    Eur J Med Chem; 2019 Sep; 178():13-29. PubMed ID: 31173968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.
    Tellam J; Fogg MH; Rist M; Connolly G; Tscharke D; Webb N; Heslop L; Wang F; Khanna R
    J Exp Med; 2007 Mar; 204(3):525-32. PubMed ID: 17312009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.
    Blake N; Haigh T; Shaka'a G; Croom-Carter D; Rickinson A
    J Immunol; 2000 Dec; 165(12):7078-87. PubMed ID: 11120837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.
    Yin Y; Manoury B; Fåhraeus R
    Science; 2003 Sep; 301(5638):1371-4. PubMed ID: 12958359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
    Blake NW; Moghaddam A; Rao P; Kaur A; Glickman R; Cho YG; Marchini A; Haigh T; Johnson RP; Rickinson AB; Wang F
    J Virol; 1999 Sep; 73(9):7381-9. PubMed ID: 10438828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Silencing of H-2D
    Tritz ZP; Orozco RC; Malo CS; Ayasoufi K; Fain CE; Khadka RH; Goddery EN; Yokanovich LT; Settell ML; Hansen MJ; Jin F; Pavelko KD; Pease LR; Johnson AJ
    J Immunol; 2020 Sep; 205(5):1228-1238. PubMed ID: 32737149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.
    Tellam J; Connolly G; Green KJ; Miles JJ; Moss DJ; Burrows SR; Khanna R
    J Exp Med; 2004 May; 199(10):1421-31. PubMed ID: 15148340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
    Lee SP; Brooks JM; Al-Jarrah H; Thomas WA; Haigh TA; Taylor GS; Humme S; Schepers A; Hammerschmidt W; Yates JL; Rickinson AB; Blake NW
    J Exp Med; 2004 May; 199(10):1409-20. PubMed ID: 15148339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
    Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
    Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
    Voo KS; Fu T; Wang HY; Tellam J; Heslop HE; Brenner MK; Rooney CM; Wang RF
    J Exp Med; 2004 Feb; 199(4):459-70. PubMed ID: 14769850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.
    Smith C; Wakisaka N; Crough T; Peet J; Yoshizaki T; Beagley L; Khanna R
    Blood; 2009 Jun; 113(24):6148-52. PubMed ID: 19372256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Moss DJ; Kurilla MG; Cooper L
    Int Immunol; 1997 Oct; 9(10):1537-43. PubMed ID: 9352359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.
    Ito Y; Demachi-Okamura A; Ohta R; Akatsuka Y; Nishida K; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    J Gen Virol; 2007 Mar; 88(Pt 3):770-780. PubMed ID: 17325349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.